147 related articles for article (PubMed ID: 34607795)
21. The diagnostic accuracy of fecal calprotectin during the investigation of suspected pediatric inflammatory bowel disease.
Henderson P; Casey A; Lawrence SJ; Kennedy NA; Kingstone K; Rogers P; Gillett PM; Wilson DC
Am J Gastroenterol; 2012 Jun; 107(6):941-9. PubMed ID: 22370604
[TBL] [Abstract][Full Text] [Related]
22. Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease.
Samant H; Desai D; Abraham P; Joshi A; Gupta T; Dherai A; Ashavaid T
Indian J Gastroenterol; 2015 Nov; 34(6):431-5. PubMed ID: 26589229
[TBL] [Abstract][Full Text] [Related]
23. Faecal calprotectin in patients with suspected colorectal cancer: a diagnostic accuracy study.
Turvill J; Aghahoseini A; Sivarajasingham N; Abbas K; Choudhry M; Polyzois K; Lasithiotakis K; Volanaki D; Kim B; Langlands F; Andrew H; Roos J; Mellen S; Turnock D; Jones A
Br J Gen Pract; 2016 Jul; 66(648):e499-506. PubMed ID: 27266863
[TBL] [Abstract][Full Text] [Related]
24. Rapid fecal calprotectin testing to assess for endoscopic disease activity in inflammatory bowel disease: A diagnostic cohort study.
Kwapisz L; Mosli M; Chande N; Yan B; Beaton M; Micsko J; Mennill PW; Barnett W; Bax K; Ponich T; Howard J; Tirolese A; Lannigan R; Gregor J
Saudi J Gastroenterol; 2015; 21(6):360-6. PubMed ID: 26655130
[TBL] [Abstract][Full Text] [Related]
25. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
[TBL] [Abstract][Full Text] [Related]
26. FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.
Rosenfeld G; Greenup AJ; Round A; Takach O; Halparin L; Saadeddin A; Ho JK; Lee T; Enns R; Bressler B
World J Gastroenterol; 2016 Sep; 22(36):8211-8. PubMed ID: 27688663
[TBL] [Abstract][Full Text] [Related]
27. Fecal Calprotectin to Detect Inflammatory Bowel Disease in Juvenile Idiopathic Arthritis.
Ferrara G; Pastore S; Sancin L; Torelli L; Radillo O; Bramuzzo M; Bibalo C; Tommasini A; Ventura A; Taddio A
J Rheumatol; 2018 Oct; 45(10):1418-1421. PubMed ID: 29907671
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
Yang Z; Clark N; Park KT
Clin Gastroenterol Hepatol; 2014 Feb; 12(2):253-62.e2. PubMed ID: 23883663
[TBL] [Abstract][Full Text] [Related]
29. Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel disease.
Bressler B; Panaccione R; Fedorak RN; Seidman EG
Can J Gastroenterol Hepatol; 2015 Oct; 29(7):369-72. PubMed ID: 26125109
[TBL] [Abstract][Full Text] [Related]
30. Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
Heida A; Park KT; van Rheenen PF
Inflamm Bowel Dis; 2017 Jun; 23(6):894-902. PubMed ID: 28511198
[TBL] [Abstract][Full Text] [Related]
31. Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.
Lozoya Angulo ME; de Las Heras Gómez I; Martinez Villanueva M; Noguera Velasco JA; Avilés Plaza F
Gastroenterol Hepatol; 2017 Mar; 40(3):125-131. PubMed ID: 27260632
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of fecal calprotectin in assessing inflammatory bowel disease activity.
Lee YW; Lee KM; Lee JM; Chung YY; Kim DB; Kim YJ; Chung WC; Paik CN
Korean J Intern Med; 2019 Jan; 34(1):72-80. PubMed ID: 29347813
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of a faecal calprotectin care pathway for use in primary care.
Turvill J; O'Connell S; Brooks A; Bradley-Wood K; Laing J; Thiagarajan S; Hammond D; Turnock D; Jones A; Sood R; Ford A
Prim Health Care Res Dev; 2016 Sep; 17(5):428-36. PubMed ID: 26899214
[TBL] [Abstract][Full Text] [Related]
34. Selecting children with suspected inflammatory bowel disease for endoscopy with the calgranulin C or calprotectin stool test: protocol of the CACATU study.
Heida A; Van de Vijver E; Muller Kobold A; van Rheenen P
BMJ Open; 2017 May; 7(5):e015636. PubMed ID: 28554936
[TBL] [Abstract][Full Text] [Related]
35. Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.
Du L; Foshaug R; Huang VW; Kroeker KI; Dieleman LA; Halloran BP; Wong K; Fedorak RN
J Clin Gastroenterol; 2018 Mar; 52(3):235-240. PubMed ID: 28009684
[TBL] [Abstract][Full Text] [Related]
36. Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases.
Diamanti A; Colistro F; Basso MS; Papadatou B; Francalanci P; Bracci F; Muraca M; Knafelz D; De Angelis P; Castro M
Inflamm Bowel Dis; 2008 Sep; 14(9):1229-35. PubMed ID: 18398894
[TBL] [Abstract][Full Text] [Related]
37. Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.
Koulaouzidis A; Douglas S; Rogers MA; Arnott ID; Plevris JN
Scand J Gastroenterol; 2011 May; 46(5):561-6. PubMed ID: 21269246
[TBL] [Abstract][Full Text] [Related]
38. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
Saha A; Tighe MP; Batra A
Arch Dis Child Educ Pract Ed; 2016 Jun; 101(3):124-8. PubMed ID: 26848103
[TBL] [Abstract][Full Text] [Related]
39. Calprotectin in Daily Practice: Where Do We Stand in 2017?
D'Angelo F; Felley C; Frossard JL
Digestion; 2017; 95(4):293-301. PubMed ID: 28511188
[TBL] [Abstract][Full Text] [Related]
40. Faecal Calprotectin for the Diagnosis of Bowel Inflammation in Patients With Rheumatological Diseases: A Systematic Review.
Fauny M; D'Amico F; Bonovas S; Netter P; Danese S; Loeuille D; Peyrin-Biroulet L
J Crohns Colitis; 2020 Jun; 14(5):688-693. PubMed ID: 31858121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]